Target intelligence / Profile preview

Viral ligands for Natural Cytotoxicity Receptors NKp46 and NKp44 (Viral NCR ligands)

Target
Viral NCR ligands
Molecular classification
Viral protein, Glycoprotein, Lectin-binding protein, Ligand
01

Overview

Viral ligands for Natural Cytotoxicity Receptors (NCRs) NKp46 and NKp44 are a diverse group of pathogen-encoded proteins that facilitate viral recognition by the innate immune system [NIH, 2021; Frontiers in Immunology, 2019]. The most prominent members include the hemagglutinin (HA) of influenza viruses and the hemagglutinin-neuraminidase (HN) of paramyxoviruses, which bind to specific sialylated O-glycans on the extracellular domains of NKp46 and NKp44 [Blood, 2004; NIH, 2025]. This binding event triggers a signaling cascade in Natural Killer (NK) cells, leading to the release of cytotoxic granules and the lysis of infected cells [NIH, 2021; ACS, 2009]. Beyond influenza, other viral proteins such as the West Nile Virus E protein and poxvirus hemagglutinins also serve as ligands for these receptors [NIH, 2021; PLOS Pathogens, 2010]. Viruses have developed sophisticated evasion mechanisms to disrupt this interaction, such as using viral neuraminidase to remove the essential sialic acids from the NCRs [NIH, 2014; NIH, 2021]. Therapeutic strategies targeting this axis include neuraminidase inhibitors that preserve NK cell recognition and the development of monoclonal antibodies or fusion proteins designed to enhance or mimic these natural immune-activating interactions [NIH, 2021; Frontiers in Immunology, 2019].

Other names
Viral hemagglutininsViral HAViral HNPathogen-derived NCR ligandsNKp46 ligandsNKp44 ligandsViral hemagglutinin-neuraminidase
02

Mechanism of action

Binding of viral ligands (such as hemagglutinin) to sialylated residues on the NKp46 and NKp44 receptors triggers NK cell-mediated cytotoxicity and cytokine production against infected cells [NIH, 2021; Blood, 2004].

03

Biological functions

Immune responseCell killingViral entrySignal transductionNK cell activation
04

Disease associations

InfectionInfluenzaWest Nile feverDengue feverPoxvirus infectionParainfluenza
05

Safety considerations

Cytokine release syndromeViral immune evasion through receptor desialylationOff-target effects on host glycansResistance mutations in viral ligands
06

Interacting drugs

Oseltamivir

5 more in the full profile.

07

Biomarkers

NKp46 (CD335) expression levelNKp44 (CD336) expression levelSialic acid surface density on NK cellsViral load

Beyond the preview

Go deeper on Viral ligands for Natural Cytotoxicity Receptors NKp46 and NKp44 (Viral NCR ligands).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral ligands for Natural Cytotoxicity Receptors NKp46 and NKp44 (Viral NCR ligands).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call